Location
Austin
Posted
June 16, 2026
Commute
Local Area
Local Opportunity Near You!
This job is in your area. Enjoy a short commute and work close to home.
Job Description
Who is Nulixir?
Nulixir, a nano-biotechnology start-up, is a VC-backed business-to-business (B2B) company that develops, manufactures, and licenses intellectual property (IP) for smart nanocarriers, called nanovesicles, which optimize the performance of functional ingredients in food & beverage products. Nulixir, as the Function HouseTM, is revolutionizing the functional ingredient space by introducing a realm of functionality and shaping the future of intelligent food. This patented technology (70+ patents) has applications across multiple verticals in food and beverage (e.g., nootropics, energy stimulants, vitamins, probiotics, protein, etc.).
Founded in 2019, the company brought together a team of CPG leaders, cancer researchers, US attorneys, and nutritionists to overcome long-standing challenges in the Food and Beverage Industry. The firmβs founder has extensive experience in the development of nanocarriers for cancer therapeutics.
...
Nulixir, a nano-biotechnology start-up, is a VC-backed business-to-business (B2B) company that develops, manufactures, and licenses intellectual property (IP) for smart nanocarriers, called nanovesicles, which optimize the performance of functional ingredients in food & beverage products. Nulixir, as the Function HouseTM, is revolutionizing the functional ingredient space by introducing a realm of functionality and shaping the future of intelligent food. This patented technology (70+ patents) has applications across multiple verticals in food and beverage (e.g., nootropics, energy stimulants, vitamins, probiotics, protein, etc.).
Founded in 2019, the company brought together a team of CPG leaders, cancer researchers, US attorneys, and nutritionists to overcome long-standing challenges in the Food and Beverage Industry. The firmβs founder has extensive experience in the development of nanocarriers for cancer therapeutics.
...